Skip to main content
. 2017 Mar 13;13(5):2957–2964. doi: 10.3892/ol.2017.5847

Figure 1.

Figure 1.

Diagram of the disease assessment for the patients with intrahepatic cholangiocarcinoma. CT, computed tomography; MRI, magnetic resonance imaging; ECOG-PS, Eastern Cooperative Oncology Group-performance status; ECG, electrocardiogram; po, bid; taken orally, twice daily.